An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Study Identifier
GMA-US-EYE-0272
CT.gov Identifier
NCT02188173
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone 700 ㎍ intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of DME in at least one eye treated OZURDEX® per clinical practice
    Exclusion Criteria:
    * None

    Protocol Summary

    This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).

    Study Locations

    Location
    Status
    Location
    Retinal Consultants of Phoenix
    Phoenix, Arizona, United States, 85014
    Status
    Not applicable
    Location
    West Coast Retina
    San Francisco, California, United States, 94109
    Status
    Not applicable
    Location
    Orange Co Retina Medical Group
    Santa Ana, California, United States, 92705
    Status
    Not applicable
    Location
    Bay Area Retina Associates
    Walnut Creek, California, United States, 94598
    Status
    Not applicable
    Location
    Colorado Retina Associates
    Denver, Colorado, United States, 80230
    Status
    Not applicable
    Location
    Illinois Retina Associates
    Harvey, Illinois, United States, 60426
    Status
    Not applicable
    Showing {first} - {last} of {total} Results